This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
MINT-VENLAFAXINE XR
MINT PHARMACEUTICALS INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MINT-VENLAFAXINE XR in Canada?
Yes. MINT-VENLAFAXINE XR 150MG has an active shortage reported to Health Canada (last updated June 12, 2026).
Why is MINT-VENLAFAXINE XR not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will MINT-VENLAFAXINE XR be available again?
The manufacturer's estimated resolution date is December 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
VENLAFAXINE XR
Extended-ReleasePHARMASCIENCE INC
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
DR. REDDY'S LABORATORIES INC
M-VENLAFAXINE XR
Extended-ReleaseMANTRA PHARMA INC
RIVA-VENLAFAXINE XR
Extended-ReleaseLABORATOIRE RIVA INC.
EFFEXOR TABLETS, 75MG
WYETH CANADA
EFFEXOR TABLETS, 37.5MG
WYETH CANADA
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-01-31
~4 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02522993
Strength
150MG
Dosage Form
CAPSULE (EXTENDED RELEASE)
Route
ORAL
Active Ingredient
VENLAFAXINE
Tier
Unrated
Last Updated
2026-07-28
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
MINT-VENLAFAXINE XR has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
25MG · DIN 02468859
10MG · DIN 02468840
200MG · DIN 02524708
800MG · DIN 02524724
400MG · DIN 02524716
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430